z-logo
open-access-imgOpen Access
Seeking Balance Between Pain Relief and Safety
Author(s) -
William Renthal
Publication year - 2016
Publication title -
jama neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.298
H-Index - 231
eISSN - 2168-6157
pISSN - 2168-6149
DOI - 10.1001/jamaneurol.2016.0535
Subject(s) - medicine , medical prescription , opioid , pill , chronic pain , addiction , intensive care medicine , psychiatry , pharmacology , receptor
Pain is a symptom common tonumerousphysical andpsychiatric ailments andcanoftenbemanagedby treating theunderlyingcondition.However, inapproximately20millionpatients eachyear,chronicpainpersistsdespitetreatment.1,2Chronicpain is complex, heterogeneous, and poorly understood. Patientswithchronicpainexperience a decreased quality of lifeandincreasedrisk formultiplecomorbidities,costingsocietybillionsofdollars in reducedproductivityannually.Therefore,equippingphysicianswitheffectivetoolsandguidelinesfor chronic painmanagement is of paramount importance. Chronicpaincanbemanagedwithbothpharmacologicand nonpharmacologic options, such as behavioral and physical therapy. Unfortunately, insurance coverage for multidisciplinary painmanagement is limited,whichplacesmuchof the responsibility for treatingchronicpainonprimarycareandprescriptionmedications.Multiplepharmacologicoptionsareavailable, including nonsteroidal anti-inflammatory drugs, antidepressants, anticonvulsants, andopioids,but it is rarelypossible to predict the safest andmost effectivemedication for a given patient. Moreover, there is a paucity of clinical trials to guide physicians in treating chronic pain. In some cases, opioids are the only class ofmedications to which a patient responds, but becauseofdangerousadverseeffects, including respiratorydepression, unintentional overdose, and addiction, it is important for physicians, especially those inprimary care, to be confident with prescribing them safely. The clinical decision to prescribe opioids must also be made in the setting of increases in opioid prescriptions and prescription opioid–related deaths, which now exceed 200 million prescriptions and 16000 deaths per year (Figure). About half of those who died had an active opioid prescription; the other half obtained opioids through pill diversion.5 Notably, among diverted opioid prescriptions, more than 50% are obtained freely from a family member or friend with a valid prescription. This reality forces prescribing physicians to simultaneously address the risk for opioid overdose in their own patients, as well as the risk of prescriptions being diverted and harming others. Related article at jama.com Related article at jamainternalmedicine.com Figure. Opioid Prescriptions andOpioid-Related Deaths From 1999-2013

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom